Uncategorized

The ₹380-crore IPO received an overall subscription of 1.23 times on Day 3, with bids for 70.31 lakh shares against 57.06 lakh shares on offer, according to NSE data.

Coforge partners with VHC Health for digital upgrades and wins a $158M UK contract, strengthening its global presence and cybersecurity efforts.

Dipan Mehta of Elixir Equities prefers pharma and specialty chemicals for medium-term investments, remains cautious on IT amid AI uncertainty, and suggests exiting Info Edge stock.

LTIMindtree partners with NVIDIA to modernise CBDT’s Insight 2.0 tax analytics platform, deploying BlueVerse and AI for improved governance, compliance, and citizen services in India.

KSB shares have done well over the last 12 months, having gained over 30%, while those of Sanofi Consumer have been underperformers over the last six months.

Lamotrigine is primarily used to treat seizures. According to IQVIA data, the estimated market size for the product is $27 million for the twelve months ending December 2025.

As of December 31, 2025, filings show that Block had a total of 10,205 employees, which will now be cut down to less than 6,000 after the layoffs.

Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.

Market breadth on Wall Street was on the positive side on Thursday, as despite a 0.5% fall on the S&P 500, more than 350 of its constituents ended with gains. 

Netflix shares surged in extended trading after it abandoned the deal with Warner Bros. Discovery, but the latter’s shares are trading with losses.